Perceived health impact of COVID-19 pandemic differs widely among vulnerable people The health impact of the COVID-19 pandemic and the associated measures is perceived very differently by vulnerable groups in society.
Half of post-traumatic stress disorder related to pandemic In autumn 2022, 3.7% of adults in the Netherlands were suffering from suspected post-traumatic stress disorder (PTSD).
Model for projecting COVID-19 hospital and ICU admissions, complete with code RIVM has published the code for model projections of COVID-19 hospital and ICU admissions. The code has been shared as part of a manuscript about the model.
Public opinion: keep society open and continue providing healthcare during COVID-19 surge In the long-term approach to the COVID-19 pandemic, the Dutch government is assigning a key role to civil society and private citizens. When asked what their priorities are in that context, the answer was to prevent delays in surgical interventions.
Repeat vaccination against COVID-19 now also available for over-60s People aged 60 to 69 years (and people who turn 60 this year) will also have the opportunity to make an appointment for an extra COVID-19 vaccination. Minister Kuipers decided this based on advice from the Health Council of the Netherlands.
Janssen booster possible as of 25 March People in the Netherlands who cannot get a booster with an mRNA vaccine for medical reasons, or do not want an mRNA vaccine as a booster, can make an appointment for a booster vaccination with Janssen from Wednesday 23 March on.
Protection from COVID-19 booster wanes slightly after 3 months among over-70s In the period from 1 February to 8 March 2022, the first indications were observed that protection against hospital admission after COVID-19 booster vaccination decreases over time in people over 7
Novavax vaccine available The Novavax vaccine is a protein-based vaccine which can offer an alternative for people who are hesitant about immunisation with an mRNA vaccine or vector vaccine, or for people who have a contraindication for mRNA vaccines.